Related Experiment Video

Updated: May 2, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis

Gang Wu1, Haiyang Liu, Hui He

  • 1Department of General Surgery, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China. wugang@mail.cmu.edu.cn.

BMC Cancer
|February 21, 2014
PubMed
Abstract

Insights

The ATAD2 gene is highly expressed in hepatocellular carcinoma (HCC), promoting cancer progression and metastasis. Inhibiting ATAD2 may offer a therapeutic strategy for liver cancer.

Area of Science:

  • Molecular biology
  • Oncology
  • Hepatocellular Carcinoma Research

Background:

  • The role of ATAD2 in hepatocellular carcinoma (HCC) remains uninvestigated.
  • ATAD2 is implicated in cellular processes including growth, migration, and invasion.

Purpose of the Study:

  • To investigate the molecular biological function of the ATAD2 gene in HCC.
  • To determine the prognostic significance of ATAD2 in HCC patients.

Main Methods:

  • Examined ATAD2 protein and mRNA expression in HCC tissues and cell lines.
  • Utilized Kaplan-Meier survival analysis and Cox regression for prognostic significance.
  • Performed ATAD2 knockdown via RNA interference to assess effects on proliferation and invasion.
  • Analyzed upstream and downstream targets using RT2 Profiler™ PCR array and luciferase assays.

Main Results:

  • ATAD2 was highly expressed in HCC tissues and correlated with poor patient survival.
  • High ATAD2 expression was linked to metastasis and served as an independent prognostic factor for HCC.
  • ATAD2 depletion reduced HCC cell invasion and proliferation, causing G1 phase arrest.
  • miR-372 was identified as an upstream regulator, directly binding to the 3' UTR of ATAD2.
  • ATAD2 knockdown significantly upregulated APC and downregulated CTNNA1 mRNA levels.

Conclusions:

  • miR-372 suppresses ATAD2 expression in HCC.
  • ATAD2 acts as a proto-oncogene in hepatic carcinogenesis, promoting HCC progression.
  • ATAD2 is a potential therapeutic target for hepatocellular carcinoma.

More Related Videos

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.0K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K